Opus Genetics, Inc. Research and Development Expense
Opus Genetics, Inc. (IRD) reported Research and Development Expense of $149.59 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-10-29
- Opus Genetics, Inc. research and development expense for the quarter ending 2020-09-30 was $149.59K, a 86.78% decline year-over-year.
- Opus Genetics, Inc. research and development expense for the quarter ending 2020-06-30 was $231.61K, a 85.95% decline year-over-year.
- Opus Genetics, Inc. research and development expense for the quarter ending 2020-03-31 was $456.79K, a 79.63% decline year-over-year.
- Opus Genetics, Inc. research and development expense for the quarter ending 2019-12-31 was $454.73K, a 83.34% decline year-over-year.
- Opus Genetics, Inc. research and development expense for fiscal 2019 was $5.48M, a 58.22% decline from fiscal 2018.
- Opus Genetics, Inc. research and development expense for fiscal 2018 was $13.11M, a 22.34% increase from fiscal 2017.
- Opus Genetics, Inc. research and development expense for fiscal 2017 was $10.72M, a 6.21% increase from fiscal 2016.
- Opus Genetics, Inc. research and development expense for fiscal 2016 was $10.09M, a 16.95% decline from fiscal 2015.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 132 month | Research and Development Expense 135 month | Research and Development Expense 138 month | Research and Development Expense 141 month | Research and Development Expense 144 month | Research and Development Expense 147 month | Research and Development Expense 150 month | Research and Development Expense 153 month | Research and Development Expense 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $149.59K 10-Q · filed 2020-10-29 | $381.20K derived: sum of 2 quarters · filed 2020-10-29 | $837.99K 10-Q · filed 2020-10-29 | $1.29M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||||
| 2020-06-30 | $231.61K 10-Q · filed 2020-08-14 | $688.40K 10-Q · filed 2020-08-14 | $1.14M derived: sum of 3 quarters · filed 2020-08-14 | $2.27M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||||
| 2020-03-31 | $456.79K 10-Q · filed 2020-05-07 | $911.52K derived: sum of 2 quarters · filed 2020-05-07 | $2.04M derived: sum of 3 quarters · filed 2020-10-29 | $3.69M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||||
| 2019-12-31 | $454.73K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $1.59M derived: sum of 2 quarters · filed 2020-10-29 | $3.23M derived: sum of 3 quarters · filed 2020-10-29 | $5.48M 10-K · filed 2020-02-21 | |||||||||||
| 2019-09-30 | $1.13M 10-Q · filed 2020-10-29 | $2.78M derived: sum of 2 quarters · filed 2020-10-29 | $5.02M 10-Q · filed 2020-10-29 | $7.75M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||||
| 2019-06-30 | $1.65M 10-Q · filed 2020-08-14 | $3.89M 10-Q · filed 2020-08-14 | $6.62M derived: sum of 3 quarters · filed 2020-08-14 | $9.51M derived: sum of 4 quarters · filed 2020-08-14 | |||||||||||
| 2019-03-31 | $2.24M 10-Q · filed 2020-05-07 | $4.97M derived: sum of 2 quarters · filed 2020-05-07 | $7.86M derived: sum of 3 quarters · filed 2020-05-07 | $11.29M derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||
| 2018-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $5.62M derived: sum of 2 quarters · filed 2020-02-21 | $9.05M derived: sum of 3 quarters · filed 2020-02-21 | $13.11M 10-K · filed 2020-02-21 | |||||||||||
| 2018-09-30 | $2.89M 10-Q · filed 2019-11-06 | $6.32M derived: sum of 2 quarters · filed 2019-11-06 | $10.38M 10-Q · filed 2019-11-06 | $13.64M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||
| 2018-06-30 | $3.43M 10-Q · filed 2019-08-07 | $7.49M 10-Q · filed 2019-08-07 | $10.75M derived: sum of 3 quarters · filed 2019-08-07 | $13.40M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||
| 2018-03-31 | $4.06M 10-Q · filed 2019-05-10 | $7.32M derived: sum of 2 quarters · filed 2019-05-10 | $9.97M derived: sum of 3 quarters · filed 2019-05-10 | $12.51M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||
| 2017-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $5.91M derived: sum of 2 quarters · filed 2019-03-07 | $8.45M derived: sum of 3 quarters · filed 2019-03-07 | $10.72M 10-K · filed 2019-03-07 | |||||||||||
| 2017-09-30 | $2.64M 10-Q · filed 2018-11-02 | $5.19M derived: sum of 2 quarters · filed 2018-11-02 | $7.45M 10-Q · filed 2018-11-02 | $9.54M derived: sum of 4 quarters · filed 2018-11-02 | |||||||||||
| 2017-06-30 | $2.54M 10-Q · filed 2018-08-03 | $4.81M 10-Q · filed 2018-08-03 | $6.89M derived: sum of 3 quarters · filed 2018-08-03 | $9.19M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||
| 2017-03-31 | $2.26M 10-Q · filed 2018-05-04 | $4.35M derived: sum of 2 quarters · filed 2018-05-04 | $6.65M derived: sum of 3 quarters · filed 2018-05-04 | $8.88M derived: sum of 4 quarters · filed 2018-05-04 | |||||||||||
| 2016-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $4.38M derived: sum of 2 quarters · filed 2018-03-09 | $6.62M derived: sum of 3 quarters · filed 2018-03-09 | $10.09M 10-K · filed 2018-03-09 | |||||||||||
| 2016-09-30 | $2.30M 10-Q · filed 2017-11-03 | $4.54M derived: sum of 2 quarters · filed 2017-11-03 | $8.00M 10-Q · filed 2017-11-03 | $10.92M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||
| 2016-06-30 | $2.24M 10-Q · filed 2017-08-04 | $5.71M 10-Q · filed 2017-08-04 | $8.62M derived: sum of 3 quarters · filed 2018-03-09 | $11.73M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||
| 2016-03-31 | $3.47M 10-Q · filed 2017-05-03 | $6.38M derived: sum of 2 quarters · filed 2018-03-09 | $9.49M derived: sum of 3 quarters · filed 2018-03-09 | $12.72M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||
| 2015-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $6.02M derived: sum of 2 quarters · filed 2018-03-09 | $9.26M derived: sum of 3 quarters · filed 2018-03-09 | $12.15M 10-K · filed 2018-03-09 | |||||||||||
| 2015-09-30 | $3.10M 10-Q · filed 2016-11-04 | $6.34M derived: sum of 2 quarters · filed 2016-11-04 | $9.23M 10-Q · filed 2016-11-04 | $11.45M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||
| 2015-06-30 | $3.24M 10-Q · filed 2016-08-05 | $6.13M 10-Q · filed 2016-08-05 | $8.35M derived: sum of 3 quarters · filed 2017-02-24 | $10.17M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||
| 2015-03-31 | $2.89M 10-Q · filed 2016-05-06 | $5.11M derived: sum of 2 quarters · filed 2017-02-24 | $6.94M derived: sum of 3 quarters · filed 2017-02-24 | $8.64M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||||
| 2014-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $4.04M derived: sum of 2 quarters · filed 2017-02-24 | $5.74M derived: sum of 3 quarters · filed 2017-02-24 | $7.02M 10-K · filed 2017-02-24 | |||||||||||
| 2014-09-30 | $1.82M 10-Q · filed 2015-11-02 | $3.53M derived: sum of 2 quarters · filed 2015-11-02 | $4.80M 10-Q · filed 2015-11-02 | $5.79M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-06-30 | $1.70M 10-Q · filed 2015-08-07 | $2.97M 10-Q · filed 2015-08-07 | $3.97M derived: sum of 3 quarters · filed 2016-03-14 | $4.75M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-03-31 | $1.27M 10-Q · filed 2015-05-08 | $2.27M derived: sum of 2 quarters · filed 2016-03-14 | $3.05M derived: sum of 3 quarters · filed 2016-03-14 | $3.97M derived: sum of 4 quarters · filed 2016-03-14 | $39.80M 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | $994.26K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.78M derived: sum of 2 quarters · filed 2016-03-14 | $2.70M derived: sum of 3 quarters · filed 2016-03-14 | $3.25M 10-K · filed 2016-03-14 | $38.53M 10-K · filed 2014-03-21 | ||||||||||
| 2013-09-30 | $781.28K 10-Q · filed 2014-11-12 | $1.71M derived: sum of 2 quarters · filed 2014-11-12 | $2.26M 10-Q · filed 2014-11-12 | $2.52M derived: sum of 4 quarters · filed 2014-11-12 | $37.54M 10-Q · filed 2013-11-13 | ||||||||||
| 2013-06-30 | $925.13K 10-Q · filed 2014-08-13 | $1.48M 10-Q · filed 2014-08-13 | $1.74M derived: sum of 3 quarters · filed 2014-08-13 | $2.81M derived: sum of 4 quarters · filed 2014-08-13 | $36.76M 10-Q · filed 2013-08-12 | ||||||||||
| 2013-03-31 | $552.47K 10-Q · filed 2014-05-14 | $818.16K derived: sum of 2 quarters · filed 2014-05-14 | $1.88M derived: sum of 3 quarters · filed 2014-05-14 | $2.90M derived: sum of 4 quarters · filed 2014-05-14 | $35.83M 10-Q · filed 2013-05-09 | ||||||||||
| 2012-12-31 | $265.69K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $1.33M derived: sum of 2 quarters · filed 2014-03-21 | $2.35M derived: sum of 3 quarters · filed 2014-03-21 | $3.39M 10-K · filed 2014-03-21 | $35.28M 10-K · filed 2013-03-22 | ||||||||||
| 2012-09-30 | $1.07M 10-Q · filed 2013-11-13 | $2.08M derived: sum of 2 quarters · filed 2013-11-13 | $3.13M 10-Q · filed 2013-11-13 | $4.61M derived: sum of 4 quarters · filed 2013-11-13 | $35.01M 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | $1.02M 10-Q · filed 2013-08-12 | $2.06M 10-Q · filed 2013-08-12 | $3.55M derived: sum of 3 quarters · filed 2013-08-12 | $5.92M derived: sum of 4 quarters · filed 2013-08-12 | $33.95M 10-Q · filed 2012-08-08 | ||||||||||
| 2012-03-31 | $1.04M 10-Q · filed 2013-05-09 | $2.53M derived: sum of 2 quarters · filed 2013-05-09 | $4.90M derived: sum of 3 quarters · filed 2013-05-09 | $10.32M derived: sum of 4 quarters · filed 2013-05-09 | $32.93M 10-Q · filed 2012-05-09 | ||||||||||
| 2011-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $3.86M derived: sum of 2 quarters · filed 2013-03-22 | $9.27M derived: sum of 3 quarters · filed 2013-03-22 | $11.99M 10-K · filed 2013-03-22 | |||||||||||
| 2011-09-30 | $2.37M 10-Q · filed 2012-11-08 | $7.79M derived: sum of 2 quarters · filed 2012-11-08 | $10.51M 10-Q · filed 2012-11-08 | $11.99M derived: sum of 4 quarters · filed 2012-11-08 | |||||||||||
| 2011-06-30 | $5.42M 10-Q · filed 2012-08-08 | $5.44M 10-Q · filed 2011-08-09 | $8.13M 10-Q · filed 2012-08-08 | $8.17M 10-Q · filed 2011-08-09 | $9.62M derived: sum of 3 quarters · filed 2012-08-08 | $10.29M derived: sum of 4 quarters · filed 2012-08-08 | |||||||||
| 2011-03-31 | $2.72M 10-Q · filed 2012-05-09 | $4.20M derived: sum of 2 quarters · filed 2012-05-09 | $4.87M derived: sum of 3 quarters · filed 2012-05-09 | $6.20M derived: sum of 4 quarters · filed 2012-05-09 | |||||||||||
| 2010-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $2.15M derived: sum of 2 quarters · filed 2012-03-16 | $3.48M derived: sum of 3 quarters · filed 2012-03-16 | $3.93M 10-K · filed 2012-03-16 | |||||||||||
| 2010-09-30 | $671.34K 10-Q · filed 2011-11-09 | $2.00M derived: sum of 2 quarters · filed 2011-11-09 | $2.45M 10-Q · filed 2011-11-09 | ||||||||||||
| 2010-06-30 | $1.33M 10-Q · filed 2011-08-09 | $1.82M 10-Q · filed 2011-08-09 | |||||||||||||
| 2009-12-31 | $3.18M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |